We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleModulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.AuthorsMichlmayr, A.; Bachleitner-Hofmann, T.; Baumann, S.; Marchetti-Deschmann, M.; Rech-Weichselbraun, I.; Burghuber, C.; Pluschnig, U.; Bartsch, R.; Graf, A.; Greil, R.; Allmaier, G.; Steger, G.; Gnant, M.; Bergmann, M.; Oehler, R.PublicationBritish Journal of Cancer, 2010, Vol 103, Issue 8, p1201ISSN0007-0920Publication typearticleDOI10.1038/sj.bjc.6605909